Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Gut

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 1 · 50%Moderate 0 · 0%High 0 · 0%

IV iron isomaltoside vs oral iron

Number of responders · IBD patients

IV iron isomaltoside showed no clear difference in number of responders ‐ remission or mild disease (8 weeks) compared with oral iron sulphate (low certainty).

1 finding from 1 review

Interventions for treating iron deficiency anaemia in inflammatory bowel disease 2021 · Cochrane Headline outcomes only
RR 1.12 [0.93, 1.34]
1 study · 338 participants
Low

IV iron isomaltoside vs oral iron

Serious adverse events ‐ remission or mild disease (8 weeks) · IBD patients

It is very uncertain whether IV iron isomaltoside changes serious adverse events ‐ remission or mild disease (8 weeks) compared with oral iron sulphate (very low certainty).

1 finding from 1 review

Interventions for treating iron deficiency anaemia in inflammatory bowel disease 2021 · Cochrane Headline outcomes only
RR 4.02 [0.51, 31.73]
1 study · 338 participants
Very low